TY  - GEN
AU  - Belhabri,Amine
AU  - Thomas,Xavier
AU  - Wattel,Eric
AU  - Chelghoum,Youcef
AU  - Anglaret,Bruno
AU  - Vekhoff,Anne
AU  - Reman,Oumedaly
AU  - Dombret,Hervé
AU  - Dhedin,Nathalie
AU  - Michallet,Mauricette
AU  - Fière,Denis
AU  - Archimbaud,Eric
TI  - All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial
SN  - 1466-4860
PY  - 2003///0725
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cytarabine
KW  - Female
KW  - Humans
KW  - Idarubicin
KW  - Leukemia, Myeloid
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Survival Analysis
KW  - Therapeutic Equivalency
KW  - Treatment Outcome
KW  - Tretinoin
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1038/sj.thj.6200141
ER  -